Lingyun Chen

Lingyun Chen


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
zhanlong meizhanlong mei
zhanlong mei
XNXiaolian Ning
Xiaolian Ning
HDHaoke Deng
Haoke Deng
LCLingyun Chen
Lingyun Chen
YZYun Zhao
Yun Zhao
JZJin Zi
Jin Zi
Spatial metabolomics is a rapidly advancing field offering powerful insights into metabolic heterogeneity in biological tissues. However, its widespread adoption is hindered by fragmented tools and the lack of comprehensive, open-source GUI software covering the full analytical workflow (quality control, preprocessing, identification, pattern, and differential analysis). To address this, we developed SMAnalyst, an open-source, integrated web-based platform. SMAnalyst consolidates core functionalities, including multi-dimensional data quality assessment (background consistency, intensity, missing values), a comprehensive metabolite annotation scoring system (mass accuracy, isotopic similarity, adduct evidence), and dual-dimension spatial pattern discovery (metabolite co-expression and pixel clustering). It also offers flexible differential analysis (cluster- or user-defined regions). With its intuitive GUI and modular workflow, SMAnalyst significantly lowers the analysis barrier, by providing a unified solution that eliminates the need for tool switching and advanced computational skills. Tested with a mouse brain dataset, SMAnalyst efficiently handles large-scale data (e.g., >14,000 pixels, >3000 ion peaks), effectively filling a critical gap in integrated analytical solutions for spatial metabolomics.

11 August 2015 in Mitochondrial DNA Part A
Verified
Journal Article
Closed access
PDF file
LCLingyun Chen
Lingyun Chen
XSXiaolei Song
Xiaolei Song
XCXi Chen
Xi Chen
XDXiao Dang
Xiao Dang
WWWen-Jing Wang
Wen-Jing Wang
Pundamilia nyererei (Perciformes, Cichlidae) is a member of Cichlid fishes that lives in the Great Lakes of East Africa. Fishes of the Cichlidae family can adapt spectacular trophic radiations and provide good potential examples of vertebrate adaptive radiations. Here, we firstly assembled the complete mitochondrial genome (mitogenome) of Pundamilia nyererei. The mitgenome was 16 761 bp in length, including 13 protein-coding genes, 22 transfer RNA genes, 2 ribosomal RNA genes and 1 putative control region. Most of these protein-coding genes started with a traditional ATG codon except for COX1, which initiated with an infrequent start codon GTG instead, and terminated with the mitochondrial stop codon (TAA/AGG/AGA) or a single T base. The mitogenome structural organization is identical to other Cichlid fish. The overall GC content is 45.25%, which is lower than the AT content. According to these new determined mitogenome sequences and 10 other species under the same family or order, we have constructed the species phylogenetic tree to verify the accuracy of newly assembled mitogenome sequences. We accept that by taking the advantage of full mitogenome, we can address taxonomic issue and study the related evolutionary events. Our current data are going to provide important resources for the research of Cichlid fishes mitochondrial evolution and energy metabolism.

9 September 2020 in medRxiv
Verified
Preprint
Open access
PDF file
HQHuan Qi
Huan Qi
MMMing-Liang Ma
Ming-Liang Ma
HJHe-Wei Jiang
He-Wei Jiang
JLJianya LING
Jianya LING
LCLingyun Chen
Lingyun Chen
JJJeremy Jiang
Jeremy Jiang
SARS-CoV-2 specific IgG responses play critical roles for patients to recover from COVID-19, in-depth dissecting of the IgG responses on systems level is of great interest. Herein, we adopted a newly developed high-throughput epitope mapping technology (AbMap), analyzed 55 COVID-19 convalescent sera and 226 antibody samples enriched by specific proteins or peptides from these sera. We revealed three areas that are rich of IgG epitopes, two are on Spike protein but outside of RBD, and one is on Nucleocapsid protein. We identified 29 significant epitopes on Spike protein, from two of these significant epitopes, two critical epitope residues were found, i. e ., D936 and P1263, which are highly related to the infectivity of SARS-CoV-2 In summary, we provided the first global map of IgG binding epitopes for SARS-CoV-2 at single amino acid resolution. This map will facilitate the precise development of therapeutic antibodies and vaccines. HIGHLIGHTS: A map of SARS-CoV-2 specific IgG binding epitopes at single amino acid resolution Two areas outside of RBD that are rich of significant epitopes were identified One area rich of significant epitopes was determined on Nucleocapsid protein Two critical epitope residues (D936 and P1263) on Spike protein are highly related to the infectivity of SARS-CoV-2

19 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
zhanlong meizhanlong mei
zhanlong mei
XNXiaolian Ning
Xiaolian Ning
HDHaoke Deng
Haoke Deng
LCLingyun Chen
Lingyun Chen
YZYun Zhao
Yun Zhao
JZJin Zi
Jin Zi
Spatial metabolomics is a rapidly advancing field offering powerful insights into metabolic heterogeneity in biological tissues. However, its widespread adoption is hindered by fragmented tools and the lack of comprehensive, open-source GUI software covering the full analytical workflow (quality control, preprocessing, identification, pattern, and differential analysis). To address this, we developed SManalyst, an open-source, integrated web-based platform. SManalyst consolidates core functionalities, including multi-dimensional data quality assessment (background consistency, noise, intensity, missing values), a comprehensive metabolite annotation scoring system (mass accuracy, isotopic similarity, adduct evidence), and dual-dimension spatial pattern discovery (metabolite co-expression and pixel clustering). It also offers flexible differential analysis (cluster- or user-defined regions). With its intuitive GUI and modular workflow, SManalyst significantly lowers the analysis barrier. Tested with a mouse brain dataset, SManalyst efficiently handles large-scale data (e.g., >14,000 pixels, >3,000 ion peaks), effectively filling a critical gap in integrated analytical solutions for spatial metabolomics. The platform is freely accessible at https://metax.genomics.cn/app/smanalyst.

29 September 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
MYMeicai Yue
Meicai Yue
LZLongjian Zhou
Longjian Zhou
WHWanrong He
Wanrong He
BLBin Li
Bin Li
ZYZhiyou Yang
Zhiyou Yang
YZYi Zhang
Yi Zhang
Background: Alzheimer’s disease (AD) is a complex neurodegenerative disorder with a global impact, highlighting an urgent need for effective dietary therapeutic agents for the development of brain-healthy functional foods and medicines. This study focuses on the edible red alga Pterocladiella capillacea from Zhanjiang, China, investigating its anti-neuronal injury activity, active principles, and underlying mechanisms. Methods: Based on antioxidant and neuroprotection evaluations and column fractioning, bioactivity-coupled liquid chromatography-tandem mass spectrometry (Bio-LC-MS/MS) was employed to recognize the neuroprotective compounds, which were further annotated by comprehensive metabolomics analysis. The annotated compounds were validated by LC-MS/MS and bioassay. Computational prediction techniques were further used to reveal their mechanism of action. Results: The study demonstrated that P. capillacea extract and fractions exhibited significant antioxidant and anti-neuronal injury activities. Among the annotated and MS-validated potential compounds, erucamide standard exhibited the strongest neuroprotective effect, maintaining cell viability above 85% at low concentrations. Network pharmacology and molecular docking revealed that erucamide may exert neuroprotective effects by modulating the AKT1 and BCL2 targets. ADMET prediction suggested a low risk of central side effects. Conclusions: The neuroprotective potential of P. capillacea provides a primary foundation for new brain-healthy functional foods and drug development in future.